Susquehanna International Group (Ireland)’s Evogene EVGN Stock Holding History

Susquehanna International Group (Ireland)’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,332	Closed	-$8.66K	–	120
2024 Q2	$8.66K	Hold	1,332	–	–	﹤0.01%	79
2024 Q1	$9.86K	Buy	+1,332	New	+$11.1K	﹤0.01%	77
2022 Q3	–	Sell	-2,872	Closed	-$21K	–	69
2022 Q2	$21K	Sell	2,872 -335	-10%	-$3.27K	0.01%	84
2022 Q1	$42K	Buy	3,207 +32	+1%	+$431	0.01%	62
2021 Q4	$55K	Sell	3,175 -1,080	-25%	-$24.5K	0.02%	59
2021 Q3	$113K	Buy	4,255 +1,441	+51%	+$42K	0.03%	73
2021 Q2	$96K	Buy	+2,814	New	+$110K	0.03%	62

Other funds holding EVGN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

RIG

Renaissance Investment Group Lenox, Massachusetts $508M AUM 30.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Susquehanna International Group (Ireland)'s EVGN Position: Q3 2024 in Review

Susquehanna International Group (Ireland) sold out of Evogene (EVGN) in Q3 2024, closing a stake of 1,332 shares — an estimated $8.66K sold.

Susquehanna International Group (Ireland) first reported a position in EVGN in Q2 2021 and held it in 7 quarters. The position peaked at $113K in Q3 2021. 14 funds tracked by Wall St. Rank hold EVGN as of Q3 2024.

Susquehanna International Group (Ireland) reported no remaining Evogene position as of Q3 2024 after selling out during the quarter.
Susquehanna International Group (Ireland) sold 1,332 Evogene shares in Q3 2024, an estimated $8.66K.
Susquehanna International Group (Ireland) first reported a position in Evogene in Q2 2021 and held it in 7 quarters.
Susquehanna International Group (Ireland)'s Evogene position peaked at $113K in Q3 2021.
14 funds tracked by Wall St. Rank held Evogene as of Q3 2024.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q3 2024, filed 14 Nov 2024.